Direct Adherence Measurement Using an Ingestible Sensor Compared With Self-Reporting in High-Risk Cardiovascular Disease Patients Who Knew They Were Being Measured: A Prospective Intervention.
David ThompsonTeresa MackayMaria MatthewsJudith EdwardsNicholas S PetersSusan B ConnollyPublished in: JMIR mHealth and uHealth (2017)
This integrated system was well tolerated in a group of 21 patients over an appreciable time frame. Its ability to measure adherence reveals the sizeable disconnect between patient self-reported adherence and actual medication taking and has promising potential for clinical use as a tool to encourage better medication-taking behavior due to its ability to provide continuous patient-level feedback.
Keyphrases
- cardiovascular disease
- end stage renal disease
- adverse drug
- case report
- newly diagnosed
- healthcare
- ejection fraction
- randomized controlled trial
- chronic kidney disease
- prognostic factors
- glycemic control
- peritoneal dialysis
- type diabetes
- emergency department
- metabolic syndrome
- risk assessment
- patient reported outcomes
- cardiovascular risk factors
- human health